American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer.
暂无分享,去创建一个
E. Winer | R. Wahl | S. Edge | M. Somerfield | A. Giuliano | A. Wolff | G. Lyman | R. Turner | D. Weaver | H. Burstein | H. Cody | J. Hayman | Cheryl L Perkins | D. Podoloff | A. Benson | D. Bodurka | A. Cochran | S. Galper | Theodore Y Kim | V. Sivasubramaniam | Cheryl L. Perkins | Theodore Kim
[1] J. Pickren. Significance of occult metastases. A study of breast cancer , 1961, Cancer.
[2] H. Rockette,et al. Detection and significance of occult axillary node metastases in patients with invasive breast cancer , 1978, Cancer.
[3] C. Redmond,et al. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. , 1981, Surgery, gynecology & obstetrics.
[4] P. Saigo,et al. Occult axillary lymph node metastases from breast cancers with intramammary lymphatic tumor emboli , 1982, The American journal of surgical pathology.
[5] N. Cascinelli,et al. Risk of Internal Mammary Lymph Node Metastases and Its Relevance on Prognosis of Breast Cancer Patients , 1983, Annals of surgery.
[6] C. Erlichman,et al. Male breast cancer: a 13-year review of 89 patients. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] D. Mason,et al. The immunocytochemical detection of axillary micrometastases in breast cancer. , 1984, British Journal of Cancer.
[8] N. Cascinelli,et al. Prognosis of Breast Cancer Patients after Mastectomy and Dissection of Internal Mammary Nodes , 1985, Annals of surgery.
[9] G. MacKenzie,et al. Long‐term survival following cancer of the male breast in Northern Ireland. A report of 81 cases , 1985, Cancer.
[10] B Fisher,et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. , 1985, The New England journal of medicine.
[11] J. Coindre,et al. Micrometastases to axillary lymph nodes from carcinoma of breast: detection by immunohistochemistry and prognostic significance. , 1987, British Journal of Cancer.
[12] J. Coindre,et al. Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer follow-up. , 1992, British Journal of Cancer.
[13] D L Morton,et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. , 1992, Archives of surgery.
[14] P. Borgen,et al. Current management of male breast cancer. A review of 104 cases. , 1992, Annals of surgery.
[15] A. Lee,et al. Occult axillary lymph node metastases in "node-negative" breast carcinoma. , 1993, Human pathology.
[16] J. Tjandra,et al. Detection and significance of occult metastases in node‐negative breast cancer , 1993, The British journal of surgery.
[17] D. Weaver,et al. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. , 1993, Surgical oncology.
[18] I. Fentiman,et al. Male breast cancer. , 1993, British journal of hospital medicine.
[19] M. Ross,et al. The Orderly Progression of Melanoma Nodal Metastases , 1994, Annals of surgery.
[20] E. Gamelin,et al. Male breast cancer: results of the treatments and prognostic factors in 397 cases. , 1995, European journal of cancer.
[21] C. O'brien,et al. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes , 1995, Melanoma research.
[22] J. G. Schuler,et al. The new era in breast cancer. Invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening. , 1996, Archives of surgery.
[23] M. Cummings,et al. Occult axillary node metastases in breast cancer: their detection and prognostic significance. , 1996, British Journal of Cancer.
[24] T. Yeatman,et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. , 1996, JAMA.
[25] M. Reiss,et al. Reappraisal of the role of axillary lymph node dissection in the conservative treatment of breast cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] A. Hanlon,et al. Identification of women with T1‐T2 breast cancer at low risk of positive axillary nodes , 1997, Journal of surgical oncology.
[27] A E Giuliano,et al. Sentinel lymphadenectomy in breast cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] R. Foster,et al. The sentinel node in breast cancer--a multicenter validation study. , 1998, The New England journal of medicine.
[29] H. Cody,et al. Sentinel lymph node biopsy in breast cancer: unfiltered radioisotope is superior to filtered. , 1999, Journal of the American College of Surgeons.
[30] S. Gapstur,et al. Factors associated with axillary lymph node metastasis from breast carcinoma , 1999, Cancer.
[31] B. Gusterson,et al. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer , 1999, The Lancet.
[32] A. Luini,et al. Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients , 1999, Cancer.
[33] A. Luini,et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. , 1999, Journal of the National Cancer Institute.
[34] R P Bleichrodt,et al. Reliability of intraoperative frozen section and imprint cytological investigation of sentinel lymph nodes in breast cancer , 1999, Histopathology.
[35] H. Cody,et al. Sentinel node biopsy in male breast cancer. , 1999, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[36] L. Mariani,et al. The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-year results of a randomised trial. , 1999, European journal of cancer.
[37] I. Bleiweiss,et al. Lymphatic invasion, tumor size, and age are independent predictors of axillary lymph node metastases in women with T1 breast cancers. , 1999, Annals of surgery.
[38] A. Rademaker,et al. Learning sentinel node biopsy: results of a prospective randomized trial of two techniques. , 1999, Surgery.
[39] A. Giuliano,et al. Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging. , 1999, The American journal of surgical pathology.
[40] D L Morton,et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. , 1999, Annals of surgery.
[41] S. Korourian,et al. Subareolar versus peritumoral injection for location of the sentinel lymph node. , 1999, Annals of surgery.
[42] H. Cody,et al. CASE REPORT: Sentinel node biopsy in male breast cancer , 1999 .
[43] D. Promish. Prediction of axillary lymph node involvement of women with invasive breast carcinoma , 1999 .
[44] H. Cody,et al. Lessons learned from 500 cases of lymphatic mapping for breast cancer. , 1999, Annals of surgery.
[45] Andreas Shamiyeh,et al. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma , 2000, Cancer.
[46] L. Liberman,et al. Sentinel Lymph Node Biopsy: Is It Indicated in Patients With High-Risk Ductal Carcinoma-In-Situ and Ductal Carcinoma-In-Situ With Microinvasion? , 2000, Annals of Surgical Oncology.
[47] S. Lakhani,et al. Radiation safety of the sentinel lymph node technique in breast cancer , 2000, European Journal of Nuclear Medicine.
[48] Stephen W Duffy,et al. A novel method for prediction of long-term outcome of women with T1a, T1b, and 10–14 mm invasive breast cancers: a prospective study , 2000, The Lancet.
[49] H. Curtin,et al. Lymph node pathology. Benign proliferative, lymphoma, and metastatic disease. , 2000, Radiologic clinics of North America.
[50] D. Weaver,et al. Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma , 2000, Cancer.
[51] A. Alastrué,et al. Sentinel node biopsy as a practical alternative to axillary lymph node dissection in breast cancer patients: an approach to its validity. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.
[52] V. Livolsi,et al. Recommendations for Handling Radioactive Specimens Obtained by Sentinel Lymphadenectomy , 2000, The American journal of surgical pathology.
[53] Philip I. Haigh,et al. Biopsy Method and Excision Volume Do Not Affect Success Rate of Subsequent Sentinel Lymph Node Dissection in Breast Cancer , 2000, Annals of Surgical Oncology.
[54] A E Giuliano,et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[55] A. Giuliano,et al. Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node , 2000, Cancer.
[56] R. Simmons,et al. Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients. , 2000, Journal of the American College of Surgeons.
[57] S. Edge,et al. Prognostic factors in breast cancer , 2005 .
[58] L. Soot,et al. Sentinel node biopsy and internal mammary lymphatic mapping in breast cancer. , 2000, American journal of surgery.
[59] P B Cerrito,et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[60] J. Aarsvold,et al. Sentinel node staging of early breast cancer using lymphoscintigraphy and the intraoperative gamma-detecting probe. , 2000, Seminars in nuclear medicine.
[61] S. Schnitt,et al. Is radiation alone adequate treatment to the axilla for patients with limited axillary surgery? Implications for treatment after a positive sentinel node biopsy. , 2000, International journal of radiation oncology, biology, physics.
[62] D. Mankoff,et al. Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma. , 2000, Cancer.
[63] K. Kern,et al. Preoperative lymphoscintigraphy during lymphatic mapping for breast cancer: improved sentinel node imaging using subareolar injection of technetium 99m sulfur colloid. , 2000, Journal of the American College of Surgeons.
[64] J. V. van Sandick,et al. The hidden sentinel node in breast cancer , 2002, European Journal of Nuclear Medicine and Molecular Imaging.
[65] A. Lucci,et al. National practice patterns of sentinel lymph node dissection for breast carcinoma. , 2001, Journal of the American College of Surgeons.
[66] L. Travaini,et al. Sentinel node biopsy in male breast cancer: future standard treatment? , 2001, The European journal of surgery = Acta chirurgica.
[67] M. Levine,et al. Clinical practice guidelines for the care and treatment of breast cancer: 13. Sentinel lymph node biopsy. , 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[68] A. Haid,et al. Is sentinel lymph node biopsy reliable and indicated after preoperative chemotherapy in patients with breast carcinoma? , 2001, Cancer.
[69] D. Byrd,et al. Axillary web syndrome after axillary dissection. , 2001, American journal of surgery.
[70] J. Connolly,et al. ADASP recommendations for processing and reporting of lymph node specimens submitted for evaluation of metastatic disease. , 2001, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[71] D. Reintgen,et al. Clinical relevance of internal mammary node mapping as a guide to radiation therapy. , 2001, American journal of surgery.
[72] Robert C. G. Martin,et al. Dermal Injection of Radioactive Colloid Is Superior to Peritumoral Injection for Breast Cancer Sentinel Lymph Node Biopsy: Results of a Multiinstitutional Study , 2001, Annals of surgery.
[73] A. Derossis,et al. A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer. , 2001, Journal of the American College of Surgeons.
[74] P. V. van Diest,et al. Predictive factors for metastatic involvement of nonsentinel nodes in patients with breast cancer. , 2001, Archives of surgery.
[75] H. Cody,et al. Is It Really Duct Carcinoma In Situ? , 2001, Annals of Surgical Oncology.
[76] H. Cody,et al. Lymphovascular Invasion Enhances the Prediction of Non-Sentinel Node Metastases in Breast Cancer Patients With Positive Sentinel Nodes , 2001, Annals of Surgical Oncology.
[77] A. Escobedo,et al. Gamma probe sentinel node localization and biopsy in breast cancer patients treated with a neoadjuvant chemotherapy scheme , 2001, Nuclear medicine communications.
[78] K. McMasters,et al. Defining the Optimal Surgeon Experience for Breast Cancer Sentinel Lymph Node Biopsy: A Model for Implementation of New Surgical Techniques , 2001, Annals of surgery.
[79] K. Kahn,et al. Arm edema in breast cancer patients. , 2001, Journal of the National Cancer Institute.
[80] K. McMasters,et al. Predicting the status of the nonsentinel axillary nodes: a multicenter study. , 2001, Archives of surgery.
[81] M. Mazumdar,et al. Complementarity of Blue Dye and Isotope in Sentinel Node Localization for Breast Cancer: Univariate and Multivariate Analysis of 966 Procedures , 2001, Annals of Surgical Oncology.
[82] L. Tafra,et al. Preoperative chemotherapy and sentinel lymphadenectomy for breast cancer. , 2001, American journal of surgery.
[83] D. Winchester,et al. Lymphedema after sentinel lymphadenectomy for breast carcinoma , 2001, Cancer.
[84] ADASP Recommendations for Processing and Reporting of Lymph Node Specimens Submitted for Evaluation of Metastatic Disease , 2001, Modern Pathology.
[85] A. Derossis,et al. Intradermal isotope injection is superior to intramammary in sentinel node biopsy for breast cancer. , 2001, Surgery.
[86] T. Julian,et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer. , 2001, American journal of surgery.
[87] P. Schrenk,et al. Sentinel-node biopsy in axillary lymph-node staging for patients with multicentric breast cancer , 2001, The Lancet.
[88] L. Tafra,et al. Multicenter Trial of Sentinel Node Biopsy for Breast Cancer Using Both Technetium Sulfur Colloid and Isosulfan Blue Dye , 2001, Annals of surgery.
[89] D. Reintgen,et al. Learning curves for breast cancer sentinel lymph node mapping based on surgical volume analysis. , 2001, Journal of the American College of Surgeons.
[90] E. Port,et al. Sentinel lymph node biopsy in patients with male breast carcinoma , 2001, Cancer.
[91] D. Reintgen,et al. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection. , 2001, Archives of surgery.
[92] T. Tuttle,et al. Educating patients on sentinel lymph node dissection for breast cancer. , 2001, Cancer practice.
[93] M. Kissin,et al. Positive sentinel node biopsy in male breast carcinoma , 2001, ANZ journal of surgery.
[94] H. Cody,et al. Comprehensive review of the management of internal mammary lymph node metastases in breast cancer. , 2001, Journal of the American College of Surgeons.
[95] C. Balch,et al. AJCC Cancer Staging Manual. 6th ed , 2002 .
[96] H. Cody,et al. Reoperative sentinel lymph node biopsy: a new option for patients with primary or locally recurrent breast carcinoma. , 2002, Journal of the American College of Surgeons.
[97] Umberto Veronesi,et al. Proceedings of the Consensus Conference on the Role of Sentinel Lymph Node Biopsy in Carcinoma of the Breast April 19–22, 2001, Philadelphia, PA, USA , 2002 .
[98] C. Compton,et al. AJCC Cancer Staging Manual , 2002, Springer New York.
[99] R. Kreienberg,et al. Shoulder-arm morbidity following axillary dissection and sentinel node only biopsy for breast cancer. , 2002, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[100] Donald L Weaver,et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[101] S. Corcione,et al. Sentinel Node Biopsy in the Evaluation of the Internal Mammary Node Chain in Patients with Breast Cancer , 2002, Tumori.
[102] K. Kern,et al. Concordance and validation study of sentinel lymph node biopsy for breast cancer using subareolar injection of blue dye and technetium 99m sulfur colloid. , 2002, Journal of the American College of Surgeons.
[103] A. Giuliano,et al. Proceedings of the Consensus Conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19–22, 2001, Philadelphia, Pennsylvania , 2002, Cancer.
[104] H. Cody,et al. Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer. , 2002, Anesthesia and analgesia.
[105] D. Reintgen,et al. Age and Body Mass Index May Increase the Chance of Failure in Sentinel Lymph Node Biopsy for Women with Breast Cancer , 2002, The breast journal.
[106] L. Vallow,et al. Is nodal irradiation necessary in breast cancer patients with positive sentinel node biopsy without axillary dissection , 2002 .
[107] S. Hollenbeck,et al. Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer. , 2002, American journal of surgery.
[108] F. Peintinger,et al. Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients , 2003, British Journal of Cancer.
[109] Alicia Samuels,et al. Cancer Statistics, 2003 , 2003, CA: a cancer journal for clinicians.
[110] T. Saida,et al. The place of lymphatic mapping and sentinel node biopsy in oncology , 2003, International Journal of Clinical Oncology.
[111] Rebecca Ottesen,et al. Emergence of sentinel node biopsy in breast cancer as standard-of-care in academic comprehensive cancer centers. , 2003, Journal of the National Cancer Institute.
[112] L. Sobin,et al. Classification of isolated tumor cells , 2003, Cancer.
[113] J. Kuhn,et al. Preliminary Outcome Analysis in Patients With Breast Cancer and a Positive Sentinel Lymph Node Who Declined Axillary Dissection , 2003, Annals of Surgical Oncology.
[114] C. Nos,et al. Impact of Internal Mammary Sentinel Node Imaging in Breast Cancer , 2003, Clinical nuclear medicine.
[115] S. Mithani,et al. Lymphatic Mapping and Sentinel Lymphadenectomy After Preoperative Therapy for Stage II and III Breast Cancer , 2004, Annals of Surgical Oncology.
[116] A. Chang,et al. Sentinel node biopsy prior to neoadjuvant chemotherapy. , 2003, American journal of surgery.
[117] H. Cody,et al. The accuracy of sentinel lymph node biopsy in multicentric and multifocal invasive breast cancers. , 2003, Journal of the American College of Surgeons.
[118] G. Hortobagyi,et al. Neoadjuvant chemotherapy for breast carcinoma , 2003, Cancer.
[119] Umberto Veronesi,et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. , 2003, The New England journal of medicine.
[120] M. Wallack,et al. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[121] M. Schijven,et al. Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. , 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[122] J. Gallegos-Hernández,et al. [lymphatic Mapping and Sentinel Lymph Node Biopsy in patients with Breast Cancer ]. , 2003, Gaceta medica de Mexico.
[123] M. Golshan,et al. Sentinel Lymph Node Biopsy Lowers the Rate of Lymphedema When Compared with Standard Axillary Lymph Node Dissection , 2003, The American surgeon.
[124] A. Giuliano,et al. Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes. , 2003, Archives of surgery.
[125] Hiram S. Cody,et al. A Nomogram for Predicting the Likelihood of Additional Nodal Metastases in Breast Cancer Patients With a Positive Sentinel Node Biopsy , 2003, Annals of Surgical Oncology.
[126] L. Newman,et al. Histopathologic Evidence of Tumor Regression in the Axillary Lymph Nodes of Patients Treated With Preoperative Chemotherapy Correlates With Breast Cancer Outcome , 2003, Annals of Surgical Oncology.
[127] A. Luini,et al. Safety of sentinel node biopsy in pregnant patients with breast cancer. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.
[128] D. McCready,et al. Influence of the new AJCC breast cancer staging system on sentinel lymph node positivity and false-negative rates. , 2004, Journal of the National Cancer Institute.
[129] Mark C Kelley,et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. , 2004, American journal of surgery.
[130] H. Schirrmeister,et al. Sentinel-node biopsy for axillary staging in breast cancer: results from a large prospective German multi-institutional trial. , 2004, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[131] Sentinel node biopsy (SNB) in breast cancer , 2004 .
[132] R. Uren,et al. Nuclear medicine aspects of melanoma and breast lymphatic mapping. , 2004, Seminars in oncology.
[133] B. Hesse,et al. Factors of importance for scintigraphic non-visualisation of sentinel nodes in breast cancer , 2005, European Journal of Nuclear Medicine and Molecular Imaging.
[134] S. Singletary,et al. Evaluation of Lymph Node Status in Male Breast Cancer Patients: A Role for Sentinel Lymph Node Biopsy* , 2004, Breast Cancer Research and Treatment.
[135] H. Cody,et al. The Risk of Axillary Relapse After Sentinel Lymph Node Biopsy for Breast Cancer Is Comparable With That of Axillary Lymph Node Dissection: A Follow-up Study of 4008 Procedures , 2004, Annals of surgery.
[136] Hiroki Koyama,et al. Usefulness of a solid‐state gamma camera for sentinel node identification in patients with breast cancer , 2005, Journal of surgical oncology.
[137] R. Newcombe,et al. Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer , 2006, Breast Cancer Research and Treatment.
[138] S. Duffy,et al. Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[139] G. Hortobagyi,et al. Male breast cancer , 1998, The Lancet.
[140] A. Cruz,et al. Analysis of sentinel lymph node mapping with immediate pathologic review in patients receiving preoperative chemotherapy for breast carcinoma , 2002, Annals of Surgical Oncology.
[141] H. Thaler,et al. Sensory morbidity after sentinel lymph node biopsy and axillary dissection: A prospective study of 233 women , 2002, Annals of Surgical Oncology.
[142] C. Ewing,et al. Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer , 2002, Annals of Surgical Oncology.
[143] Mary J. Nissen,et al. Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer , 2002, Annals of Surgical Oncology.
[144] K. McMasters,et al. The effect of prior breast biopsy method and concurrent definitive breast procedure on success and accuracy of sentinel lymph node biopsy , 2002, Annals of Surgical Oncology.